Details for New Drug Application (NDA): 040910
✉ Email this page to a colleague
The generic ingredient in OXYCODONE AND ASPIRIN is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
Summary for 040910
| Tradename: | OXYCODONE AND ASPIRIN |
| Applicant: | Epic Pharma Llc |
| Ingredient: | aspirin; oxycodone hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 040910
| Mechanism of Action | Cyclooxygenase Inhibitors Full Opioid Agonists |
| Physiological Effect | Decreased Platelet Aggregation Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 040910
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OXYCODONE AND ASPIRIN | aspirin; oxycodone hydrochloride | TABLET;ORAL | 040910 | ANDA | Epic Pharma, LLC | 42806-061 | 42806-061-01 | 100 TABLET in 1 BOTTLE (42806-061-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 325MG;4.8355MG | ||||
| Approval Date: | Jul 16, 2020 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
